Matthew B. Rettig
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Cancer Research top 1%
- Biomedical Engineering top 2%
- Co-authors
- Jiabin AnRobert E. ReiterJiaoti HuangYiping SunAlan LichtensteinDino Di CarloMyrna FisherJérémie Calais
- Topics
- Prostate Cancer Treatment and Research (101 papers)Radiopharmaceutical Chemistry and Applications (47 papers)Prostate Cancer Diagnosis and Treatment (39 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Matthew B. Rettig
160 papers receiving 6.4k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 2.4k
- Pulmonary and Respiratory Medicine 2.1k
- Molecular Biology 2.0k
- Cancer Research 1.4k
- Biomedical Engineering 1.3k
Countries citing papers authored by Matthew B. Rettig
This map shows the geographic impact of Matthew B. Rettig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew B. Rettig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew B. Rettig more than expected).
Fields of papers citing papers by Matthew B. Rettig
This network shows the impact of papers produced by Matthew B. Rettig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew B. Rettig. The network helps show where Matthew B. Rettig may publish in the future.
Co-authorship network of co-authors of Matthew B. Rettig
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew B. Rettig. A scholar is included among the top collaborators of Matthew B. Rettig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew B. Rettig. Matthew B. Rettig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 10 | |
| 8 | 6 | |
| 9 | 10 | |
| 10 | 2 | |
| 11 | 40 | |
| 12 | 92 | |
| 13 | 64 | |
| 14 | 45 | |
| 15 | 1 | |
| 16 | 133 | |
| 17 | 62 | |
| 18 | 77 | |
| 19 | 45 | |
| 20 | 94 |
About Matthew B. Rettig
Matthew B. Rettig is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 171 papers that have together received 6.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (101 papers), Radiopharmaceutical Chemistry and Applications (47 papers) and Prostate Cancer Diagnosis and Treatment (39 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (2.4k citations) and Pulmonary and Respiratory Medicine (2.1k citations). Matthew B. Rettig has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Jiabin An, Robert E. Reiter, Jiaoti Huang, Yiping Sun, Alan Lichtenstein, Dino Di Carlo, Myrna Fisher, Jérémie Calais, Allan J. Pantuck and Robert Vescio. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.